Literature DB >> 18695663

Using reduced intensity conditioning and HLA-identical sibling donors, antithymocyte globulin increases the risk of relapse, which can be overcome by a high stem cell dose.

M Remberger, J Mattsson, B-M Svahn, O Ringdén.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18695663     DOI： 10.1038/bmt.2008.246

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  6 in total

1.  Different impact of intermediate and unfavourable cytogenetics at the time of diagnosis on outcome of de novo AML after allo-SCT: a long-term retrospective analysis from a single institution.

Authors:  H Nahi; M Remberger; M Machaczka; J Ungerstedt; J Mattson; O Ringden; Katarina Le-Blanc; P Ljungman; H Hägglund
Journal:  Med Oncol       Date:  2012-01-11       Impact factor: 3.064

2.  Older recipient age is paradoxically associated with a lower incidence of chronic GVHD in thymoglobulin recipients: a retrospective study exploring risk factors for GVHD in allogeneic transplantation with thymoglobulin GVHD prophylaxis.

Authors:  A B M Lim; J Storek; A Beligaswatte; M Collins; M Tacey; T Williamson; K Mason; E Li; M A Chaudhry; J A Russell; A Daly; J Szer; I Lewis; D Ritchie
Journal:  Bone Marrow Transplant       Date:  2015-02-02       Impact factor: 5.483

3.  Characterization of long-term mixed donor-donor chimerism after double cord blood transplantation.

Authors:  J Gertow; S Berglund; M Okas; M Uzunel; L Berg; K Kärre; J Mattsson; M Uhlin
Journal:  Clin Exp Immunol       Date:  2010-08-20       Impact factor: 4.330

4.  Reduced-intensity and myeloablative conditioning allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia and myelodysplastic syndrome: a meta-analysis and systematic review.

Authors:  Wen Zeng; Lifang Huang; Fankai Meng; Zeming Liu; Jianfeng Zhou; Hanying Sun
Journal:  Int J Clin Exp Med       Date:  2014-11-15

5.  Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.

Authors:  Sherif S Farag; Kati Maharry; Mei-Jie Zhang; Waleska S Pérez; Stephen L George; Krzysztof Mrózek; John DiPersio; Donald W Bunjes; Guido Marcucci; Maria R Baer; Mitchell Cairo; Edward Copelan; Corey S Cutler; Luis Isola; Hillard M Lazarus; Mark R Litzow; David I Marks; Olle Ringdén; David A Rizzieri; Robert Soiffer; Richard A Larson; Martin S Tallman; Clara D Bloomfield; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2011-06-21       Impact factor: 5.742

6.  Stable mixed donor-donor chimerism after double cord blood transplantation.

Authors:  Sofia Berglund; Mantas Okas; Jens Gertow; Michael Uhlin; Jonas Mattsson
Journal:  Int J Hematol       Date:  2009-08-22       Impact factor: 2.490
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.